Replies to post #100146 on Ayala Pharmaceuticals Inc (ADXS)

[ignatiusrielly35]

That trial design was just way too long and expensive for a company in ADXS’s position. Although I wouldn’t necessarily rule out a continuation trial if someone likes the soon to be released data. Also, PSA is still alive, let’s see what happens with that one.